ストックスクリーナーアプリを入手
65.00
3.11%
-2.2399
前日終値:
$67.24
開ける：
$66.61
24時間の取引高:
20,611
Relative Volume:
0.77
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.43%
1か月 パフォーマンス:
+20.86%
6か月 パフォーマンス:
+36.67%
1年 パフォーマンス:
+76.84%
1日の値動き範囲:
$65.07
$66.61
1週間の範囲:
$64.03
$68.00
52週間の値動き範囲:
$36.00
$68.00
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
65.07 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
379.21 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
769.00 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
772.69 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.81 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
715.85 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf (GNOM) 最新ニュース
How to Buy Moderna Stock (MRNA) in 2026 - The Motley Fool
Global X Genomics & Biotechnology UCITS ETFUSDChart Real-time | ETF | GNOG | IE00BM8R0N95 - marketscreener.com
5 Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Global X Genomics & Biotechnology ETF (GNOM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Precision Trading with Global X Genomics & Biotechnology Etf (GNOM) Risk Zones - Stock Traders Daily
GNOM Dividend: 1.12% Yield, $0.65/Share — History & Dates - GuruFocus
GNOMZ ETF Profile: Dividends, Returns (AQUISUK:GNOMZ) - TradingView
Global X Genomics & Biotechnology ETF Shs Unsponsored Brazilian Depositary Receipt Repr 0.16666667 Sh - TradingView
Technical Reactions to GNOM Trends in Macro Strategies - Stock Traders Daily
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pacific Biosciences of California Inc (PACB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CRISPR Therapeutics AG (CRSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sarepta Therapeutics Inc (SRPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Natera Inc (NTRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Qiagen NV (QGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Myriad Genetics Inc (MYGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intellia Therapeutics Inc (NTLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrowhead Pharmaceuticals Inc (ARWR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beam Therapeutics Inc (BEAM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ultragenyx Pharmaceutical Inc (RARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regenxbio Inc (RGNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scilex Holding Co (SCLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prime Medicine Inc (PRME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bio-Techne Corp (TECH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biontech SE (BNTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Legend Biotech Corp (LEGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Guardant Health Inc (GH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Twist Bioscience Corp (TWST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vir Biotechnology Inc (VIR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Moderna Inc (MRNA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
GNOM Archives - 24/7 Wall St.
ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026. - Pluang
ETF Showdown: ARKG vs GNOM, Which Genomics Fund Wins? - 24/7 Wall St.
ETFs Investing in Rocket Pharmaceuticals, Inc. Stocks - TradingView
Trading the Move, Not the Narrative: (GNOM) Edition - Stock Traders Daily
ETFs Investing in 10x Genomics Inc Class A Stocks - TradingView
GNOM ETF Profile: Dividends, Returns (NASDAQ:GNOM) - TradingView
ETFs Investing in Fulgent Genetics, Inc. Stocks - TradingView
3 of the best performing ASX ETFs to own right now - The Motley Fool Australia
Global X Genomics Biotechnology Etf (GNOM) 財務データ
Global X Genomics Biotechnology Etf (GNOM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.37%
大文字化:
|
ボリューム (24 時間):